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Recovery of Chronic Parkinsonian Monkeys
by Autotransplants of Carotid Body
Cell Aggregates into Putamen
almost abandoned because they appear to induce only
transient recovery; however, grafting of fetal mesence-
phalic neurons has been shown to produce sustained
motor improvement in parkinsonian animals and PD pa-
tients (see BjoÈ rklund and Stenevi, 1985; BjoÈ rklund et al.,
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We have recently shown that intrastriatal transplants
Summary of carotid body cell aggregates produce rapid and long-
lasting cellular and functional recovery of parkinsonian
We have studied the effect of unilateral autografts of rats (Espejo et al., 1998). The carotid bodies contain
carotid body cell aggregates into the putamen of glomus or type I cells, which derive from the neural
MPTP-treated monkeys with chronic parkinsonism. crest and are among the cells with the highest dopa-
Two to four weeks after transplantation, the monkeys mine content in the organism, and glial-like type II cells
initiated a progressive recovery of mobility with reduc- (see Fidone and GonzaÂ lez, 1986). Grafted glomus cells
tion of tremor and bradykinesia and restoration of fine showed excellent survival in the brain parenchyma,
motor abilities on the contralateral side. Apomorphine where they appeared organized in clusters emitting neu-
injections induced rotations toward the side of the rites and retaining the ability to secrete dopamine. After
transplant. Functional recovery was accompanied by some months, the presence of carotid body cells in-
the survival of tyrosine hydroxylase±positive (TH-posi- duced striatal dopaminergic reinnervation to a degree
tive) grafted glomus cells. A high density of TH-immu- similar to that existing before destruction of the substan-
noreactive fibers was seen reinnervating broad re- tia nigra (Espejo et al., 1998; our unpublished data).
gions of the ipsilateral putamen and caudate nucleus. The special durability of transplanted glomus cells could
The nongrafted, contralateral striatum remained deaf- possibly be related to their sensitivity to hypoxia, a con-
ferented. Intrastriatal autografting of carotid body tis- dition probably favored inside intracerebral grafts,
sue is a feasible technique with beneficial effects on which may act as a ªtrophicº factor inducing cell growth
parkinsonian monkeys; thus, this therapeutic approach and excitability and dopamine synthesis and release
could also be applied to treat patients with Parkinson's (Fishman et al., 1985; LoÂ pez-Barneo et al., 1988; Czyzyk-
disease. Krzeska et al., 1992; Stea et al., 1992, 1995; UrenÄ a et al.,
1994; LoÂ pez-Barneo, 1996). Due to the optimal results of
our initial study in rats, we suggested that transplanta-
tion of carotid body cell aggregates might be used toIntroduction
treat PD (Espejo et al., 1998; see also Rosenthal, 1998).
Intrastriatal autografting of carotid body tissue offersParkinson's disease (PD) results from the progressive
numerous potential clinical advantages because surgi-degeneration of dopaminergic neurons in the substantia
cal resection of carotid bodies is technically simple andnigra innervating the striatum; hence, one of the thera-
has no significant side effects in humans (reviewed bypeutic approaches to this disease has been the intrastri-
Honda, 1992).atal grafting of dopamine-secreting cells (recently re-
This study was designed to evaluate the possible ben-viewed by Hagan et al., 1997; Lang and Lozano, 1998a,
eficial effects of intrastriatal autotransplants of carotid1998b; Rosenthal, 1998). In the past 2 decades, numer-
body cell aggregates in an animal, like the monkey,ous transplantation studies have been done in animal
closer to the human in brain organization and function.models of PD as well as in Parkinson's patients using
We used two monkeys rendered parkinsonian by sys-
dopamine-rich neural and paraneural tissues. Auto-
temic administration of the neurotoxin MPTP for 10
grafts of adrenal and other paraneural cells have been
months. Transplants were performed several months
after the last MPTP injection, once the animals had
reached a severe and stable parkinsonism. So, the mon-‖To whom correspondence should be addressed (e-mail: lbarneo@
cica.es). keys presented a chronic motor syndrome resembling
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Table 1. Behavioral Recovery of Parkinsonian Monkeys after Carotid Body Grafts into the Left Putamen
MPTP Number of Doses/Months Fine Motor Task Circling
Monkey (mg/kg) after Last MPTP Dose Disability Scorea After Graft (s)b Behavior
Before
Graft After Graft Right Hand Left Hand Before Graft After Graft
CYN-1 5.25 16/3 months 20.4 6 1.1 10.8 6 0.85 5.3 6 0.1 10.1 6 0.5 (2) (1)
.80%c ,10%c
CYN-2 4.95 13/7 months 21.8 6 0.83 12.2 6 0.84 NDd NDd (2) (1)
a Average (mean 6 SEM) of five evaluation sessions.
b Time spent performing the task (mean 6 SEM of 15 complete successful trials).
c Percentage of successful trials.
d Not done.
the situation in PD patients. We here show that unilateral apomorphine, indicating a decreased dopamine recep-
tor supersensitivity in the transplanted striatum. Apo-carotid body autotransplants induced a clear ameliora-
morphine-induced rotations were already observed intion of the global parkinsonism of MPTP monkeys with
monkey CYN-1 2 weeks after grafting and were main-marked improvement of the motor abilities on the con-
tained throughout the survival period. This behavioraltralateral side of the graft. Functional recovery was par-
pattern was so pronounced that the animal was not ablealleled by survival of glomus cells in the striatum and
to move around the cage in any direction except toipsilateral reinnervation of large regions of the putamen
the left side, so it often remained still in order to avoidand the caudate nucleus.
turning.
Monkey CYN-2 received carotid body grafts into theResults
left putamen and one injection of Tyrode solution into
the right side to test for possible nonspecific effectsBehavioral Recovery of Parkinsonian Monkeys
induced by the surgical procedure. In this animal, theAfter chronic administration of MPTP, the monkeys de-
beneficial effects of the grafts, observed after the firstveloped a severe bilateral parkinsonism, which con-
month, started more slowly than in monkey CYN-1,sisted of loss of spontaneous activity, bradykinesia,
probably because it had a more severe parkinsonianimpairment of balance, postural tremor, and freezing
syndrome (Table 1). Amelioration of parkinsonism was(see supplemental movies at http://www.neuron.org/
characterized by enhanced spontaneous activity, im-cgi/content/full/22/4/743/DC1) (Langston et al., 1984;
proved balance, and reduction of contralateral bradyki-PeÂ rez-OtanÄ o et al., 1991). In monkey CYN-1, which had
nesia, which was evidenced by more skillful movementsreceived carotid body grafts into the left putamen, a
of the right hand such as the preference of the animalmarked decrease of parkinsonian features was ob-
to use it when reaching for food. At the end of the
served on the side contralateral to the implant 2 weeks
experimental period (3 months after transplantation), the
after grafting. Tremor was the first sign to ameliorate
disability score of monkey CYN-2 was reduced by 40%
followed by a slow but significant improvement of the (Table 1). The evolution of fine motor tasks could not
bradykinesia in the contralateral limbs. In addition, the be studied in monkey CYN-2 because it had not been
severity of parkinsonism clearly improved as evidenced trained before becoming parkinsonian. However, like
by increased spontaneous activity and better mainte- in monkey CYN-1, injections of apomorphine elicited
nance of posture and execution of movements. Maximal systematically, beginning the first month after the trans-
recovery was observed 2 months after grafting and re- plant, a circling behavior to the left side suggesting an
mained stable during the survival time (5 months). Dis- asymmetrical striatal sensitivity to dopamine. Apomor-
ability score was reduced by 50% (Table 1). The most phine injections induced in both monkeys abnormal
obvious consequences of carotid body implants into the movements (dyskinesias) consisting of rapid and stereo-
left putamen were the appearance of behavioral signs typed flexo-extensions of the knee, which can be attrib-
indicative of asymmetric striatal dopamine function. Be- uted to the persistence of dopamine receptor supersen-
fore becoming parkinsonian, monkey CYN-1 had been sitivity in the denervated, nongrafted striatum (Boyce et
trained to perform a fine motor task (see Experimental al., 1990; Luquin et al., 1992).
Procedures), which was executed by each hand at ap-
proximately the same speed (2.5 s total time to perform Survival of Grafted Glomus Cells
the task) and with a similar percentage of successful and Striatal Reinnervation
trials (.90%). MPTP treatment resulted in a marked Histological studies were done in brain sections stained
bilateral increase in the number of failures and in the either with thionine, for precise cytoarchitectonic local-
time spent performing the task. After implantation of ization of the needle tracts, or using an anti-TH antibody,
carotid body cells into the left putamen, the ability to to specifically identify dopaminergic cells and fibers.
perform the task with the contralateral (right) hand was Figure 1A (left and right) shows photographs at low mag-
partially recovered. This was manifested by faster move- nification of brain coronal sections at the caudal level
ments and, more importantly, by an increase in the num- of the putamen stained with thionine. The images illus-
ber of successful trials (see Table 1). Another sign of trate the symmetrical location of the carotid body graft,
striatal function asymmetry was the appearance of cir- near the center of the putamen (left), and the scar pro-
duced by the needle tract and Tyrode solution injectioncling behavior to the left side after administration of
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Figure 1. Carotid Body Grafts in Putamen and Morphological Features of TH-Positive Grafted Glomus Cells
(A) Brain coronal sections at the caudal level of the putamen of monkey CYN-2 stained with thionine. The carotid body graft in the left putamen
(left) and the lesion produced by the needle and Tyrode solution injection into the right putamen (right) are indicated by arrowheads.
(B) Differential density of dopaminergic fibers on the left and right putamen in a region near the carotid body graft (left) or the Tyrode solution
injection (right). The insets show enlargements of the areas of the carotid body graft (left) and needle scar (right) immunostained with an
antiserum against TH.
(C±E) Representative isolated TH-positive glomus cells near a graft in the left putamen. Note the ovoid or bipolar shape of some cells and
the emission of neurites (arrows) from the soma.
(F) Cluster of TH-positive glomus cells in a carotid body aggregate similar to those used for grafting.
Calibration bars: 1200 mm (A), 60 mm (B), 100 mm (insets), 12 mm (C±F).
in the right striatum (right). At the same level of the stained and appeared under the microscope with a
characteristic lighter color. Only a macrophage infiltra-putamen, TH immunoreactivity was clearly apparent on
the side of the graft, with the presence of numerous TH- tion was observed at the nongrafted putamen, which
showed a complete absence of TH-positive fibers (right).positive fibers (Figure 1B, left), whereas, as is typical in
MPTP-treated monkeys, the contralateral putamen was Individual TH-positive glomus cells were difficult to visu-
alize within the grafts, and the number was roughly esti-almost completely denervated (Figure 1B, right). The
insets in Figure 1B show at higher magnification the mated to be below 80±100 cells per injection. Due to
the lack of a specific marker of type II cells, their numberappearance of the graft with a condensation of dark-
colored TH-immunoreactive cells and fibers intermin- in the graft could not be estimated. This relatively small
number of glomus cells observed was not unexpected,gled with macrophages (left) that were nonspecifically
Neuron
746
since we detected in the carotid bodies resected from carotid body transplant±mediated migration of dopa-
minergic neurons from the unlesioned hemisphere toMPTP-treated monkeys an interstitial fibrosis and a low
density of TH-immunoreactive glomus cells. Examples the contralateral, 6-OHDA-lesioned side of the brain. As
was described for carotid body implants in rats (Espejoof individual TH-positive glomus cells located at the
periphery of the graft with the characteristic ovoid or et al., 1998), some glomus cells adopted ovoid or fusi-
form shape and grew long neurites. The number of TH-bipolar shape and emission of long neurites are shown
in Figures 1C±1E. For a comparison, Figure 1F illustrates positive glomus cells that could be detected in the grafts
was relatively small as compared with the number ofat the same magnification a group of glomus cells from
a piece of the same carotid body used for the transplant. glomus cells surviving in grafted rats (Espejo et al.,
1998). In carotid bodies from MPTP monkeys, we ob-Besides the long survival of carotid body cells and
the appearance of TH-positive fibers near the grafts, a served a sparse distribution of TH-immunoreactive cells,
so it is likely that a lower number of TH-positive cellsstriking morphological feature of transplanted monkeys
was the reinnervation of large regions of the ipsilateral was transplanted. Although the number of cases studied
is obviously too small, it appears that chronic MPTPstriatum. Figure 2A shows at low magnification the
marked contrast of TH-positive staining between the treatment damages a population of glomus cells or in-
duces them to be TH negative. Nevertheless, glomusleft and right putamen contained in the same coronal
section of the brain. The areas included in the rectangles cells seem to be highly resistant to MPTP since, in spite
of the high vascularization of the carotid body, a largeare shown enlarged in Figure 2B to illustrate the appear-
ance of a dense striatal innervation by TH-positive fibers proportion of cells maintained a TH-positive phenotype
after chronic intravenous administration of the neuro-on the side ipsilateral to the grafts (left) and the sparse
appearance of dopaminergic fibers on the right side of toxin. In contrast, ,0.1% of substantia nigra cells, prob-
ably receiving a smaller amount of MPTP, remained THthe brain. The difference in dopaminergic innervation
between the left and right striata was apparent even at positive. Resistance to MPTP is possibly a characteristic
of peripheral catecholaminergic neurons, since it isthe level of the head of the caudate nucleus (Figures 2C
and 2D), several millimeters rostral to the location of the known that this neurotoxin does not significantly affect
mouse adrenal catecholamine levels (Bohn et al., 1987).carotid body implants.
Increased resistance to MPTP could result from the ex-
pression of a lower density of dopamine transporterDiscussion
in carotid body cells as compared to substantia nigra
neurons (our unpublished data).Our results indicate that unilateral autologous trans-
Transplanted TH-positive glomus cells appeared in-plants of carotid body cell aggregates into the putamen
tensely stained, indicating that they were metabolicallyameliorate the severity of parkinsonism in chronically
active and capable of releasing dopamine in the graftMPTP-treated monkeys. Carotid body resection and in-
and neighboring regions. In fact, dopamine release hastrastriatal grafting of the tissue can be easily performed
been demonstrated to occur inside intrastriatal carotidin the same operatory act and, as is already known of
body grafts in rats (Espejo et al., 1998). However, thehumans (see Honda, 1992), carotid body removal did
broad reinnervation observed in distant regions of thenot produce any appreciable alteration in the monkeys.
putamen and caudate nucleus suggests that carotidAmelioration of the parkinsonian symptoms started
body cell aggregates activated sprouting of spared do-between 2 and 4 weeks after transplantation and pro-
paminergic cells or induced TH expression in other neu-gressed or was sustained throughout the 3±5 months
rons (or differentiation of neural progenitors) after trans-of the study. Disability score was reduced in the two
plantation. Intrinsic reinnervation has been postulatedtransplanted monkeys by 40%±50%; however, further
to occur after adrenal (Freed et al., 1981; Bohn et al.,amelioration of parkinsonism could have possibly been
1987) and carotid body (Espejo et al., 1998) grafts inobtained with bilateral implants. Behavioral recovery
rats and is not related to brain injury or reactive gliosiswas paralleled by the presence of TH-immunoreactive
since, as shown here, the level of TH-immunoreactiveglomus cells in the graft and ipsilateral dopaminergic
fibers was almost negligible on the sham-operated sidereinnervation of large regions of the putamen and the
of the brain. Thus, it seems that carotid body, and possi-caudate nucleus. The behavioral and histological im-
bly other paraneural cells, may produce trophic factorsprovement of transplanted monkeys cannot be simply
that stimulate dopaminergic neurons to grow and sprout.explained by recovery with time since in each monkey
The high concentration of neurotrophic substances inthe nontransplanted side, which served as internal con-
the carotid body (within either glomus cells, type II cells,trol, remained denervated. Tyrode injection into the right
or both; see below) and the long survival of graftedputamen of one of the monkeys also failed to induce
carotid body cell aggregates are factors that can explainreinnervation or recovery of function attributable to that
why a few hundred or a thousand implanted cells arehemisphere. Moreover, chronic MPTP monkeys with
able to induce reinnervation of large regions of the stria-similar features as those used in this study are known
tum and significant functional recovery. As already sug-to exhibit progressive and persistent loss of striatal do-
gested (Espejo et al., 1998), the durability of glomus cellspamine and signs of neuronal degeneration several
in low oxygen tension, a condition likely strengthenedyears after the MPTP treatment (for a recent work, see
within intracerebral grafts, may facilitate their adaptationBrownell et al., 1998). The ipsilateral striatal reinnerva-
and survival in the brain parenchyma. It has also beention observed in transplanted monkeys rules out the
shown in embryonic and neonatal rats that the carotidremote possibility that what was seen in the rodent
hemi-parkinsonian model (Espejo et al., 1998) was a body is one of the organs outside the CNS with the
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Figure 2. Ipsilateral Reinnervation of Putamen and Caudate Nucleus after Grafting Carotid Body Cell Aggregates into the Left Putamen
(A and B) Coronal sections at the level of the putamen processed for TH immunohistochemistry in monkey CYN-1 (A). Note the difference in
staining between the left (grafted) and right sides of the brain. The areas in the rectangles are shown in (B) at higher magnification to illustrate
the differential density of TH-positive fibers.
(C and D) TH immunohistochemistry of coronal sections at the level of the head of the caudate nucleus in monkey CYN-1 (C). The difference
in fiber staining between the left (grafted) and right sides of the brain in the areas indicated by the rectangles can be appreciated at higher
magnification in (D).
Calibration bars: 300 mm (A and C), 60 mm (B and D).
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continuous blood pressure and EKG monitoring. Surgery started byhighest concentration of glial cell line±derived neuro-
exposing the superficial neck muscles in the vicinity of the lowertrophic factor (GDNF) (Nosrat et al., 1996). GDNF and
maxilla, identifying the submandibular gland, and opening the ca-related molecules represent a family of growth factors
rotid sheath, usually found under the digastric muscle, which had
belonging to the transforming growth factor b superfam- to be sectioned in order to expose the carotid bifurcation. Removal
ily, which are extraordinarily potent (active at picomolar of the carotid body was performed under microscopy by dissecting
concentrations) and capable of promoting survival and out of the carotid wall all tissue from the last portion of the common
carotid artery to several millimeters above the origin of both internaldifferentiation of mesencephalic dopaminergic neurons
and external carotid arteries. The neck incision was sutured in layers.in vivo and in vitro (Lin et al., 1993; Poulsen et al., 1994;
After removal, the carotid body was processed following the sameTomac et al., 1995; Gash et al., 1996; Horger et al.,
basic methodology described by Espejo et al. (1998). Briefly, the1998). Interestingly, GDNF gene expression in the adult
carotid body was cleaned of surrounding adipose and connective
striatum is known to be upregulated by electrical excita- tissue and trimmed into pieces of z0.2±0.3 mm in diameter. A small
tion (Schmidt-Kastner et al., 1994), a condition favored piece was fixed and processed for histological examination (see
by acute and chronic hypoxia in glomus cells (LoÂ pez- below). The tissue was incubated for 20 min in Ca21- and Mg21-free
Tyrode solution with collagenase (1 mg/ml), trypsin (1 mg/ml), andBarneo et al., 1988; Stea et al., 1992, 1995; UrenÄ a et al.,
DNase (0.5 mg/ml). Cell aggregates were washed and resuspended1994). Intrastriatal injection of GDNF can elicit dopamin-
in 5 ml of normal Tyrode solution to remove the enzyme. Duringergic reinnervation in parkinsonian rats (Rosenblad et
carotid body processing, the animal was placed in the stereotaxical., 1998), and a high single dose of GDNF in chronic
frame and deep anesthesia was maintained with a mixture of keta-
parkinsonian monkeys also induces functional activa- mine (10 mg/kg) and midazolam (1 mg/kg). A hole was drilled in the
tion of nigral dopaminergic neurons and increased do- skull at the level of the right frontal ventricle according to the atlas
pamine levels in the globus pallidus (Gash et al., 1996). of Szabo and Cowan (1984), and a ventriculography was performed
by injecting 0.4 ml of Omnigrass into the right ventricle. The inter-GDNF injection alone, however, does not produce any
commissural line (AC±PC line) was measured and the coordinatessignificant increase of dopamine levels in the monkey
for the putamen nucleus were adjusted according to the atlas. Incaudate nucleus and putamen (Gash et al., 1996), which
both animals, carotid body cell aggregates (three to five per tract)contrasts with the pattern of dopaminergic reinnervation
were injected into the left putamen in two sites along the rostrocau-
observed in the present study after carotid body grafts. dal axis using a Hamilton microsyringe. In CYN-2, one additional
Therefore, it is possible that, besides GDNF, carotid injection of Tyrode solution (2 ml) was delivered into the right puta-
body cells can also express other factors (see Kotzbauer men at the caudal level. The putamen coordinates used were as
follows: rostral putamen, AP 13.4 mm from the midpoint of theet al., 1996; Baloh et al., 1998; Milbrandt et al., 1998)
AC±PC line, ML 12 mm from the longitudinal sinus, and VD 15 mmthat promote dopaminergic neurons.
below dura mater; and caudal putamen, AP midpoint of the AC±PCIn conclusion, unilateral intrastriatal autotransplants
line, ML 12.4 mm lateral from the longitudinal sinus, and VD 15 mmof carotid body cell aggregates can induce amelioration
below dura mater. Animals received antibiotics (ampicillin 250 mg/
of chronic parkinsonism in MPTP monkeys and marked day, i.m.) prophylactically for 2 weeks and analgesia with nonsteroi-
recovery of the motor abilities on the contralateral side dal anti-inflammatory drugs (flunixin, 2.5 mg/kg).
of the implant. Functional recovery is paralleled by sur-
vival of glomus cells and marked dopaminergic rein- Behavioral and Pharmacological Assessment
nervation of the ipsilateral striatum, which might be due Motor deficits induced by MPTP were assessed according to a
nonhuman primate disability rating scale, which scores indepen-to the release of growth factors from carotid body cells.
dently from 0 (normal) to 3 (maximal disability) parkinsonian featuresFurther studies to characterize the presence and regula-
such as tremor (intensity and duration), bradykinesia, posture, bal-tion of dopaminergic neuron±promoting trophic factors
ance, feeding, and freezing and from 0 (normal) to 5 (maximal disabil-in the carotid body are essential. Finally, the present
ity) the reduction in spontaneous activity, thus giving a total maximal
paper should lead to clinical investigations aimed at score of 25 (Herrero et al., 1993). Monkey CYN-1 had been trained
assessing the efficacy of carotid body autotransplants before becoming parkinsonian to perform a fine motor task con-
in PD patients. sisting in the capture of four peanuts with each of the two hands.
Time spent in performing the motor task was measured every 2
weeks (see Table 1). In addition, apomorphine (0.1 mg/kg, i.m.) wasExperimental Procedures
also given every 2 weeks to test the appearance of circling behavior
as a consequence of decreased dopamine receptor supersensitivityAnimals
Two Cynomolgus monkeys (Macaca fascicularis), CYN-1 and CYN-2, in the grafted striatum. After carotid body grafting, evaluations were
were used in these experiments. Animals were housed in a room undertaken every other week. The disability scores given in Table
under standard conditions of humidity (50%), air exchange (16 l/min), 1 are average values of five evaluations done during the last 2 weeks
and dark/light cycles (8 a.m. to 8 p.m.). They were fed fresh fruit before transplantation (before graft) and sacrifice (after graft). All
and commercial pellets and had free access to water. Both animals the evaluation sessions were recorded on standardized video tapes.
were rendered parkinsonian by weekly intravenous injections of
the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Histology(0.5±1 mg/kg, total MPTP dose 16.6 and 14.3 mg) for 10 consecutive
At the end of the experimental period (5 and 3 months after graftingmonths. Marked reduction of spontaneous activity, bilateral action
for CYN-1 and CYN-2, respectively), animals were transcardiallytremor, and posture and balance impairment were the most promi-
perfused with 4% paraformaldehyde in PB. The brains were post-nent features observed after concluding MPTP exposure. To avoid
fixed overnight in the same fixative at 48C and then immersed inthe possibility that spontaneous recovery, which usually occurs after
30% sucrose in PBS until brain dissection. Coronal sections, 30 mmMPTP administration, could resemble the behavioral effect of ca-
thick, were cut on a freezing microtome and collected in PB. Tissuerotid body grafting, animals were allowed to recover from the last
sections were incubated in PB with Triton X-100 (0.3%) and normalMPTP dose for at least 3 months prior to transplantation (see Table
sheep serum for 30 min. Sections were incubated overnight in agita-1). All experiments were carried out according to the European
tion with a monoclonal anti-TH antibody (1/1000, Boehringer-Mann-Communities Council Directive of November 24, 1986 (86/609/EEC).
heim). Subsequently, the sections were incubated in biotinylated
anti-mouse antibody (1/200, Boehringer-Mannheim). The vectorSurgery and Intracerebral Grafting
ABC procedure 1:100 (vectasin elite ABC kit, Vector Laboratories)Unilateral carotid body resection and stereotaxic surgery were per-
formed under general anesthesia with endotracheal intubation and was followed without blocking endogenous peroxidase. Staining for
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peroxidase was performed in buffer acetate imidazole (0.125 M Survival of implanted fetal dopamine cells and neurologic improve-
ment 12 and 46 months after transplantation for Parkinson's disease.acetate and 0.010 imidazole [pH 7.2]) using 0.05% diaminobenzi-
N. Engl. J. Med. 327, 1549±1555.dine, 0.001% H2O2, and 0.1% NiSO4 for 2±10 min. After washing in
PB, sections were mounted in gelatin-coated slides, dehydrated, Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman,
and coverslipped without counterstaining. Neural elements con- J., Russell, D., Martin, D., Lapchak, P.A., Collins, F., et al. (1996).
taining TH were visualized as blue-black. Nonspecifically stained Functional recovery in parkinsonian monkeys treated with GDNF.
macrophages typically appeared with a lighter color. A similar proce- Nature 380, 252±254.
dure as in the brain was applied to the piece of carotid body removed Hagan, J.J., Middlemiss, D.N., Sharpe, P.C., and Poste, G.H. (1997).
during animal surgery. Some sections of the brain were not used Parkinson's disease: prospects for improved drug therapy. Trends
for TH immunocytochemistry but for staining with thionine to better Pharmacol. Sci. 18, 156±163.
localize the needle tract. Herrero, M.T., PeÂ rez-OtanÄ o, Y., Oset, C., Kastner, A., Hirsch, E.C.,
Agid, Y., Luquin, M.R., Obeso, J.A., and Del RõÂo, J. (1993). GM-1
Acknowledgments ganglioside promotes the recovery of surviving midbrain dopamin-
ergic neurons in MPTP-treated monkeys. Neuroscience 56, 965±972.
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